NASDAQ: RLMD - Relmada Therapeutics, Inc.
Lønnsomhet i seks måneder: -90.4%
Utbytte: 0.00%
Sektor: Healthcare
Nyheter
Ingen nyheter funnet ennå for "Relmada Therapeutics, Inc."
